Sage Therapeutics has said it will cut its headcount ... to launch Zurzuvae and help women suffering with PPD," said Sage's CEO, Barry Greene . "Executing on launch and our potential long ...

CEO Tim Dyer Addex is getting a CHF 5 million ... agreed to an $8.7 billion takeover by AbbVie – as well as Sage Therapeutics/Biogen, which got FDA approval last year for GABAA receptor PAM ...

Sage Therapeutics faces challenges with a 90% value drop but shows promise with Zurzuvae for postpartum depression. Click ...

President and CEO, Kymera Therapeutics. “Noah’s demonstrated leadership and business acumen will support Kymera’s continued growth as we advance our expanding pipeline through clinical development and ...

Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced ...

We are thrilled to welcome Jessica to the RAPT leadership team at this pivotal time for the company,” said Brian Wong, M.D., Ph.D., President and CEO of RAPT. “With her deep expertise as both an ...

The Netherlands-based, Nasdaq-listed company said Monday it appointed Dennis Hom as finance chief and Cristina Lopez Lopez as chief medical officer to support the advancement of its Axiomer platform ...

“We were probably one of the lucky few that was able to go out last fall and have such a strong and successful IPO,” Bicara ...

Tony Sage, Critical Metals CEO joined the Bloomberg Open Interest C-Suite to talk about how difficult it would be to diversify the rare earth supply chain away from China and how Greenland plays a ...